What's in Taro Pharmaceutical Industries's pipeline?

Taro Pharmaceutical Industries has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Taro Pharmaceutical Industries's portfolio?

Top competitors by shared drug class: , Aqua Pharms, Astellas Pharma, AstraZeneca K.K., Eurofarma.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/taro.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Taro Pharmaceutical Industries — Portfolio Competitive Intelligence Brief

Taro Pharmaceutical Industries (TARO) pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

TARO (NYSE) 2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ovide	MALATHION	marketed	Cholinesterase Inhibitor [EPC]	Melatonin receptor type 1A	Neuroscience	1982-01-01
Topicort	DESOXIMETASONE	marketed	Corticosteroid [EPC]	Glucocorticoid receptor	Oncology	1977-01-01

Therapeutic area mix

Neuroscience · 1
Oncology · 1

Recent regulatory actions (last 90 days)

2026-03-16 — Topicort · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2026-05-26 — Topicort · 8715624 · Formulation · US
2028-09-01 — Topicort · 8277780 · Formulation · US

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Aqua Pharms · 1 shared drug class
Astellas Pharma · 1 shared drug class
AstraZeneca K.K. · 1 shared drug class
Eurofarma · 1 shared drug class
Generic (originally Merck) · 1 shared drug class
Generic (originally Merck/Upjohn) · 1 shared drug class
Generic (originally Schering) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Taro Pharmaceutical Industries:

Cite this brief

Drug Landscape (2026). Taro Pharmaceutical Industries — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/taro. Accessed 2026-05-13.